SCHEMBL29930718

SCHEMBL29930718

c1ccc(-c2cnc3[nH]ncc3c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 3/20 0.61
CDK8 P49336 2/20 0.61
GSK3B P49841 7/20 0.58
CDK5 Q00535 3/20 0.58
CLK4 Q9HAZ1 3/20 0.58
DYRK3 O43781 2/20 0.58
CLK2 P49760 2/20 0.58
DYRK1A Q13627 2/20 0.58
CLK1 P49759 1/20 0.58
CLK3 P49761 1/20 0.58
CDK5R1 Q15078 1/20 0.58
DYRK2 Q92630 1/20 0.58
DYRK1B Q9Y463 1/20 0.58
PIK3CA P42336 2/20 0.55
PIK3CD O00329 1/20 0.55
PIK3R1 P27986 1/20 0.55
PIK3CB P42338 1/20 0.55
MTOR P42345 1/20 0.55
PIK3CG P48736 1/20 0.55
FGFR1 P11362 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4207604 0.83 PIK3CA (0.63) AXLGSK3BCDK5CLK4DYRK3
SCHEMBL23098906 0.81 PIK3CA (0.49) AXLCDK8GSK3BCDK5CLK4
SCHEMBL29930749 0.81 KIT (0.55) DYRK1APIK3CAPIK3C3MAP4K4NTRK1
SCHEMBL24155852 0.81 MEN1 (0.51) AXLCDK8GSK3BCDK5CLK4
SCHEMBL14338803 0.81 CDK5 (0.47) AXLCDK8GSK3BCDK5CLK4
SCHEMBL29930392 0.80 PIK3C3 (0.52) AXLGSK3BCDK5CLK4DYRK3
SCHEMBL24137515 0.80 RPS6KB1 (0.52) AXLGSK3BCLK4CLK2DYRK1A
SCHEMBL11134013 0.79 TGFBR1 (0.47) AXLPIK3CAPIK3CDPIK3R1PIK3CB
SCHEMBL15639535 0.79 GSK3B (0.44) AXLCDK8GSK3BCDK5CLK4
SCHEMBL1585618 0.78 CDK8 (0.50) AXLCDK8GSK3BCDK5CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed